ABSTRACT
Objectives To determine the prevalence of food insecurity among individuals with celiac disease (CeD) and non-celiac gluten sensitivity (NCGS) in the Netherlands and explore its association with diet quality and other barriers to adherence to a gluten-free diet.
Design Mixed-method design comprising a survey and semi-structured interviews.
Setting An online survey was distributed through social media accounts and the newsletter of the Dutch Association for Celiac Disease. Community-dwelling patients were surveyed and interviewed between June and November 2023.
Participants and outcome measures In total 548 adults with CeD and NCGS in the Netherlands who adhered to a gluten-free diet completed the survey including questions related to demographics, household food security, financial stress and dietary quality. Regression analyses were conducted to assess associations between food insecurity and diet quality, and between food insecurity and perceived difficulty of gluten-free eating and cooking. Additionally, semi-structured interviews with 8 food insecure adults with CeD were conducted.
Results The prevalence of food insecurity was 23.2%, with 10.4% reporting very low food security. Very low insecurity was associated with poorer diet quality (β=-5.5; 95%CI=-9.2,-1.9; p=0.003). Food insecurity was associated with heightened perceived barriers across multiple themes, including skills, social circumstances, resources and gluten-free products, with odds ratios ranging between 1.9-4.7 for crude models (very low food security vs food security). The qualitative analysis provided a deeper understanding of these challenges, including employed strategies to manage costs and insights into the mental burden associated with adhering to a gluten-free diet.
Conclusion These findings indicate that food insecurity is prevalent among Dutch people with CeD and NCGS, with potential impact on dietary quality and adherence to a gluten-free diet. It further provided insight into perceived barriers to adhering to a gluten-free diet among this target population. These challenges should be taken into account by clinicians and policy makers.
STRENGTHS AND LIMITATIONS
The study provides previously unexplored insights in food insecurity among people with CeD and NCGS in the Netherlands.
By employing a mixed-methods study design, the quantitative findings gained added depth as they were enriched by the personal experiences elucidated in the qualitative analysis. These provided a richer understanding of the challenges individuals face, including employed strategies to manage costs and insights into the mental burden associated with adhering to a GF diet.
An inherent limitation of the study is its cross-sectional design, which prevents drawing causal conclusions regarding factors associated with food insecurity.
The study relied on self-reported data through anonymous surveys, which introduces the possibility of recall bias and social desirability bias
In the context of this study, food insecurity might be limited to ‘gluten-free food insecurity’ in otherwise food secure households.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was reviewed by the Medical Ethics Committee of Leiden University Medical Centre (LUMC) and confirmed not to be subject to the Medical Research Involving Human Subjects Act (WMO) (P17.164).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
